Montserrat Calvo - Grifols SA Chief Administrative Officer, Controller
| GIFLF Stock | USD 8.46 0.00 0.00% |
Executive
Montserrat Calvo is Chief Administrative Officer, Controller of Grifols SA since 2017.
| Tenure | 7 years |
| Phone | 34 93 571 02 21 |
| Web | https://www.grifols.com |
Grifols SA Management Efficiency
The company has return on total asset (ROA) of 0.0155 % which means that it generated a profit of $0.0155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0182 %, meaning that it generated $0.0182 on every $100 dollars invested by stockholders. Grifols SA's management efficiency ratios could be used to measure how well Grifols SA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Peter Kornicker | Novartis AG ADR | N/A | |
| John Reed | Roche Holding Ltd | 59 | |
| Felix Ehrat | Novartis AG ADR | 60 | |
| John Tsai | Novartis AG ADR | 54 | |
| David Epstein | Novartis AG ADR | 53 | |
| Andrin Oswald | Novartis AG ADR | 41 | |
| Sophie KornowskiBonnet | Roche Holding Ltd | 54 | |
| David Redfern | GlaxoSmithKline PLC ADR | 58 | |
| Alan Hippe | Roche Holding Ltd | 56 | |
| Jennifer Halchak | Organon Co | N/A | |
| Nuria Barnes | Grifols SA ADR | N/A | |
| Rebecca Edwards | Organon Co | N/A | |
| Charles Sawyers | Novartis AG ADR | 62 | |
| M Tubau | Grifols SA ADR | N/A | |
| FranoisXavier Roger | Sanofi ADR | 62 | |
| Thomas Larsen | AstraZeneca PLC ADR | N/A | |
| Gottlieb Keller | Roche Holding Ltd | 64 | |
| Urs Jaisli | Roche Holding Ltd | 62 | |
| Noriaki Yamamoto | Santen Pharmaceutical Co | N/A | |
| Victoria Whyte | GlaxoSmithKline PLC ADR | N/A | |
| Linda MD | Novartis AG ADR | 61 | |
Management Performance
| Return On Equity | 0.0182 | |||
| Return On Asset | 0.0155 |
Grifols SA Leadership Team
Elected by the shareholders, the Grifols SA's board of directors comprises two types of representatives: Grifols SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Grifols. The board's role is to monitor Grifols SA's management team and ensure that shareholders' interests are well served. Grifols SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Grifols SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Antonio Pares, Director of Planning and Control | ||
| Peter Allen, Chairman of Hospital OPS Division | ||
| Carsten Schroeder, President Of The Diagnostic Division | ||
| Albert Roura, CEO of Laboratorios Grifols SA | ||
| Jose Garcia, Director General De Laboratorios Grifols | ||
| Lafmin Morgan, President Of The Bioscience And Hospital Division | ||
| Juan Roura, Vice President of Production, Executive Director | ||
| Eva Tubau, Chief Scientific Officer | ||
| Anna Lluch, Independent Director | ||
| Carlos Fernandez, Deputy Industrial Vice President | ||
| Jose Gras, Director, Representative of Thorthol Holdings BV | ||
| Maria Llano, Chief Officer | ||
| Edgar Jannotta, Independent Director | ||
| Vicente Torre, CTO | ||
| Mateo Humbert, Director of Human Resources | ||
| Montserrat Calvo, Chief Administrative Officer, Controller | ||
| Montserrat Llamas, Chief Officer | ||
| Ramon Roca, Vice-President of Marketing and Sales and Executive Director | ||
| Vctor Deu, CoCEO Director | ||
| David Bell, Vice President of Corporate Operations and Development of Grifols Inc and United States Subsidiaries | ||
| Victor Deu, Co-CEO, Executive Director | ||
| Luis Bobadilla, Independent Director | ||
| Inigo Mardones, Director | ||
| Thomas Glanzmann, Director | ||
| Carina Lazaro, Independent Director | ||
| Joel Abelson, President of North America Commercial Division of Grifols Inc | ||
| Steven Mayer, Director | ||
| Jose Fulla, CEO of Diagnostic Industrial Group | ||
| Javier Ribes, CEO of Instituto Grifols SA | ||
| Alfredo Guerra, CFO and Corporate VP | ||
| Raimon Roura, Non-Member Secretary of the Board | ||
| Miguel Montblanch, Chariman of Global Operations Network | ||
| Victor Roura, Chairman, CEO and President and Member of Appointments and Remuneration Committee | ||
| Brett Ingersoll, Director | ||
| Shinji Wada, President of Plasma Centers of Grifols Inc | ||
| Tomas Gelabert, Director | ||
| Nuria Lapea, Risk Treasury | ||
| M Tubau, Co Affairs | ||
| Steven JD, Ex Chairman | ||
| Marla Salmon, Independent Director | ||
| Nuria Barnes, Non-Member Assistant Secretary of the Board | ||
| Gregory Rich, President of Grifols Inc and Subsidiaries in the US | ||
| Belen Morenes, Independent Director | ||
| Nuria Lapena, Director of Shareholder and Investor Relations |
Grifols Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Grifols SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0182 | |||
| Return On Asset | 0.0155 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 16.07 B | |||
| Shares Outstanding | 422.18 M | |||
| Shares Owned By Insiders | 30.57 % | |||
| Shares Owned By Institutions | 30.49 % | |||
| Price To Earning | 9.52 X | |||
| Price To Book | 1.04 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Grifols SA in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Grifols SA's short interest history, or implied volatility extrapolated from Grifols SA options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Grifols SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Grifols Pink Sheet analysis
When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |